Children’s National designated as Pediatric PKD Center of Excellence
The Inherited & Polycystic Kidney Disease (IPKD) Program within the Division of Nephrology at Children’s National Hospital has earned the prestigious designation of Pediatric Center of Excellence by the Polycystic Kidney Disease (PKD) Foundation, the only U.S. organization focused solely on advancing treatments and finding a cure for PKD.
This elite recognition is granted to nephrology practices and clinics that meet the PKD Foundation’s rigorous, patient-centered criteria for specialized PKD care. As a designated Pediatric Center of Excellence, the IPKD Program at Children’s National is recognized for its extensive experience in treating children with PKD and providing multidisciplinary care to meet the unique needs of this patient population. Awarded to only four pediatric hospitals nationwide, this highly selective honor underscores the program’s unwavering commitment to excellence in both patient care and PKD research.
“This achievement is a result of the strong partnership between the PKD Foundation and our Division of Nephrology, working together to elevate the standard of PKD care for our patients and their families,” says Ashima Gulati, MD, PhD, Pediatric Nephrologist and Director of the IPKD Program at Children’s National.
“As providers in the PKD community, we are reminded that our work is part of a broader network, with our patients and caregivers at the heart of everything we do. I’m thrilled that the Division of Nephrology at Children’s National is playing a key role in this initiative, which aligns with the PKD Foundation’s mission to advance promising therapies into clinical practice while ensuring the best possible care for PKD patients today,” Dr. Gulati added.
